Healthcare - Biotechnology - NASDAQ - NL
$ 1.57
-5.42 %
$ 41.3 M
Market Cap
-1.76
P/E
BALANCE SHEET
102 M
ASSETS
50.5 M
LIABILITIES
51.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
LAVA Therapeutics N.V.
| Current Assets | 98.9 M |
| Cash & Short-Term Investments | 95.6 M |
| Receivables | 1.7 M |
| Other Current Assets | 1.63 M |
| Non-Current Assets | 2.81 M |
| Long-Term Investments | 0 |
| PP&E | 2.49 M |
| Other Non-Current Assets | 319 K |
| Current Liabilities | 14.9 M |
| Accounts Payable | 4.45 M |
| Short-Term Debt | 5.72 M |
| Other Current Liabilities | 4.77 M |
| Non-Current Liabilities | 35.6 M |
| Long-Term Debt | 591 K |
| Other Non-Current Liabilities | 35 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 44.2 | 100.3 | 151.0 | 19.4 | 8.3 |
| Short Term Investments | 51.3 | 32.5 | 48.0 | 0 | 0 |
| Receivables | 1.7 | 3.3 | 0.7 | 1.5 | 0.2 |
| Inventory | 0 | 0 | (48.8) | 1.0 | 0 |
| Other Current Assets | 1.6 | 4.4 | 2.6 | 0.9 | 62 K |
| Total Current Assets | 98.9 | 140.5 | 154.8 | 22.4 | 8.6 |
| PP&E | 2.5 | 2.1 | 2.2 | 1.8 | 1.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.3 | 0.8 | 0.9 | 0.9 | 34 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 101.7 | 143.4 | 157.9 | 25.2 | 10.0 |
| LIABILITIES | |||||
| Accounts Payable | 4.4 | 4.0 | 2.6 | 0.9 | 0.4 |
| Short Term Debt | 5.7 | 5.0 | 0.3 | 1.7 | 0.2 |
| Other Current Liabilities | 4.8 | 12.9 | 6.9 | 3.1 | 1.0 |
| Total Current Liabilities | 14.9 | 22.0 | 5.0 | 8.8 | 1.6 |
| Long Term Debt | 0.6 | 0.4 | 4.6 | 3.9 | 1.5 |
| Deferred Tax Income | 0 | (4.7) | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 5.0 | 1.5 | 0.2 |
| Total Liabilities | 50.5 | 57.4 | 23.7 | 15.8 | 3.4 |
| EQUITY | |||||
| Common Stock | 3.7 | 3.7 | 4.1 | 0 | 0 |
| Retained Earnings | (148.1) | (108.1) | (89.3) | (44.4) | (15.5) |
| Other Accumulative Comprehensive Income/Loss | 1.1 | (4.0) | 1.3 | 0.7 | 14.7 K |
| Total Equity | 51.2 | 86.0 | 134.2 | 9.4 | 6.6 |
| Total Liabilities and Equity | 101.7 | 143.4 | 157.9 | 25.2 | 10.0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 26.7 | 25.9 | 19.8 | 25.4 | 18.4 |